Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Hoffman, Motonori Akahori, Bernard King.


Stephen Hoffman has joined Celera Genomics as senior vice president, immunotherapeutics. He will establish and lead a new team to identify disease targets using the company’s genomics and proteomics data.

Hoffman came to Celera from the US Navy, where he directed malaria research efforts. He played a key role in sequencing the genome of Plasmodium falciparum, the microbe responsible for malaria.

Hoffman and his team will initially focus on specific cancers, with the goal of developing vaccines, therapeutics, and small-molecules for treatment and prevention of the disease.

Genomic Solutions has promoted Motonori Akahori to president of its Japanese subsidiary, Genomic Solutions KK. Formerly general manager of the subsidiary, Akahori founded the Japan office of the company’s predecessor, B.I. Systems.

Akahori will serve a major role in identifying global product opportunities for Genomic Solutions.

Clinical bioinformatics company Pioneer has appointed Bernard King as president and CEO. King held a number of positions prior to joining the company, including president and COO of Advanced Bioresearch Associates, president of ChromoXome, and executive vice president for biological sciences and medical affairs at Trega Biosciences.

Filed under

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.